Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Shu‐bei Wang"'
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 13309-13318 (2023)
Abstract Background and Objectives Neoadjuvant chemotherapy (nCT) appears in a few clinical studies as an alternative to neoadjuvant chemoradiation (nCRT) in selected patients with locally advanced rectal cancer (LARC). We aimed to compare the clinic
Externí odkaz:
https://doaj.org/article/fd9ec9dd3e1c4122bc59367120b7c90f
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundMany studies have shown that the peripheral blood inflammatory index and nutritional index, such as the platelet lymphocyte ratio (PLR), neutrophil lymphocyte ratio (NLR), lymphocyte monocyte ratio (LMR), systemic inflammation response inde
Externí odkaz:
https://doaj.org/article/0b9afbfc525d4828a81257db05e3664d
Autor:
Lu Cao, Cheng Xu, Meng-Di Wang, Wei-Xiang Qi, Gang Cai, Rong Cai, Shu-Bei Wang, Dan Ou, Min Li, Kun-Wei Shen, Jia-Yi Chen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeTo determine the relationship between time to radiotherapy (TTR) and survival outcomes in breast cancer (BC) patients treated with neoadjuvant treatments (NATs).MethodsContinuous non-metastatic BC patients receiving NAT and adjuvant radiothera
Externí odkaz:
https://doaj.org/article/abaf1e74173d4295810b54672febd5b2
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeThe effect of adjuvant irradiation after mastectomy in early-stage breast cancer patients remains controversial. The present study aims to explore the clinical benefit obtained from adjuvant radiotherapy among post-mastectomy pT1-2N1 breast ca
Externí odkaz:
https://doaj.org/article/4deef3ca6bec4511a6c3b010b88d21ed
Autor:
Shu-Bei Wang, Wei-Xiang Qi, Jia-Yi Chen, Cheng Xu, Youlia M. Kirova, Wei-Guo Cao, Rong Cai, Lu Cao, Min Yan, Gang Cai
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-11 (2019)
Abstract Background Lacking quantitative evaluations of clinicopathological features and the risk factors for loco-regional recurrence (LRR) in gastric cancer after D2 gastrectomy, we aimed to develop a competing risk nomogram to identify the risk pr
Externí odkaz:
https://doaj.org/article/92b4ae21dcbb4fb2893b66768ac931ed
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundOne of the most controversial areas in gastrointestinal oncology is the benefit of postoperative chemoradiotherapy (CRT) over chemotherapy (CT) alone after D2 dissection of locally advanced gastric cancer (LAGC). We aimed to identify the LA
Externí odkaz:
https://doaj.org/article/93a8c27711f9413490f15060bac570b5
Autor:
Fei-Fei Xu, Sai-Fang Zheng, Cheng Xu, Gang Cai, Shu-Bei Wang, Wei-Xiang Qi, Chao-Fu Wang, Jia-Yi Chen, Cao Lu
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
This study aims to identify the density of TILs in ductal carcinoma in situ (DCIS) in terms of prognostic significance with recurrence and the benefit of whole breast irradiation (WBI). The clinicopathological data of DCIS patients from Jan 2009 to D
Externí odkaz:
https://doaj.org/article/74391baa13c849aa8793f4dc79ba819e
Autor:
Xuehong Zhao, Weixiang Qi, Fei-Fei Xu, Peipei Shen, Haicheng Fang, Zhenjun Jin, Jin Huang, Ying Zhang, Hui Li, Qingwen Zhao, Yu Wang, Xiaofang Qian, Xiaodong Gu, Jinrong Xie, Yu-Ting Tan, Dan Ou, Cheng Xu, Jiayi Chen, Hecheng Huang, Zefei Jiang, Lu Cao, Min Li, Yubin Wang, Shu-Bei Wang, Xiaobo Huang, Bingguang Chen
Publikováno v:
Cancer Research. 81:SS2-07
Background The outbreak of COVID-19 pandemic in China has greatly impacted the radiotherapy (RT) strategy for breast cancer (BC) patients, which might lead to an increased distressing psychological symptom. Thus, we perform a multi-center cross-secti
Autor:
Dan Ou, Rong Cai, Wei-Xiang Qi, Can Cui, Shu-Bei Wang, Huan Li, Tao Ma, Ying Miao, Cheng Xu, Gang Cai, Wei-Guo Cao, Yun-Sheng Gao, Jia-Yi Chen, Hao-Ping Xu
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Frontiers in oncology. 12
PurposeThe effect of adjuvant irradiation after mastectomy in early-stage breast cancer patients remains controversial. The present study aims to explore the clinical benefit obtained from adjuvant radiotherapy among post-mastectomy pT1-2N1 breast ca